title: Intravitreal pegaptanib reduces fluorescein leakage in idiopathic parafoveal telangiectasis.
authors: Raul N G
authors: RN
authors: Vianna
authors: Giuseppe
authors: G
authors: Squeri
authors: Remo
authors: R
authors: Turquetti
authors: O F M
authors: OF
authors: Brasil
authors: M N
authors: MN
authors: Burnier
mesh_terms: D052157:Aptamers, Nucleotide / Q000627:therapeutic use*; D002199:Capillary Permeability; D005260:Female; D019793:Fluorescein / Q000378:metabolism*; D005451:Fluorescein Angiography; D005584:Fovea Centralis; D006801:Humans; D007267:Injections; D008875:Middle Aged; D012164:Retinal Diseases / Q000188:drug therapy* / Q000378:metabolism; D012171:Retinal Vessels / Q000187:drug effects* / Q000378:metabolism; D013684:Telangiectasis / Q000188:drug therapy* / Q000378:metabolism; D041623:Tomography, Optical Coherence; D042461:Vascular Endothelial Growth Factor A / Q000037:antagonists & inhibitors; D014792:Visual Acuity; D014822:Vitreous Body
chemical_list: D052157:Aptamers, Nucleotide; D042461:Vascular Endothelial Growth Factor A; C495058:pegaptanib; D019793:Fluorescein